Therapeutic Drug Monitoring Reserach

The development of new therapeutic drug monitoring (TDM) methods is an area of intense research activity. This is due to the need for low-dose multi-drug regimens, the importance of assessing inter- and intra-individual metabolism variability, and the necessity of determining the narrow therapeutic concentration ranges of drugs. As a result, a growing number of research laboratories are turning to LC/MS/MS for research into the identification and quantitation of immunosuppressants, pain panels, antiretroviral, anticonvulsive and antipsychotic drugs.

AB SCIEX LC/MS/MS solutions quickly identify and quantify low-dose, multi-drug regimens in different matrices to provide the accuracy you need for confidence in your research results at the utmost speed and sensitivity. Moreover, compared to immunoassay-based techniques, mass spec will bring flexibility and versatility to your research, enabling you to easily add new methods to your laboratory while increasing the throughput and saving operational costs of your existing analyses.